翔宇医疗：目前，公司产品中，有相当一部分康复设备链接了脑机接口技术

Core Viewpoint - The company reported a slight increase in total revenue by 6.00% year-on-year, but net profit significantly decreased by 42.89% year-on-year, primarily due to increased R&D expenses of 126 million yuan, which rose by 20.15% year-on-year [2]. Group 1: Financial Performance - Total revenue increased by 6.00% year-on-year [2]. - Net profit decreased by 42.89% year-on-year [2]. - R&D expenses amounted to 126 million yuan, reflecting a year-on-year increase of 20.15% [2]. Group 2: R&D Focus - The company emphasizes research and development as a key driver for product innovation and upgrades [2]. - The strategic R&D direction focuses on applications in rehabilitation medicine, including brain-machine interfaces, exoskeleton robots, and artificial intelligence (AI) [2]. - The establishment of the Rehabilitation Robot Laboratory and Sun-BCI Lab for brain science indicates a commitment to advancing brain-machine interface technology [2]. - A significant portion of R&D investment is directed towards areas directly or indirectly related to brain-machine interface technology [2].